{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:54:56Z","timestamp":1792007696820,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,4]],"date-time":"2020-10-04T00:00:00Z","timestamp":1601769600000},"content-version":"vor","delay-in-days":3108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1194\/jlr.p023614","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T01:48:31Z","timestamp":1328665711000},"page":"802-809","source":"Crossref","is-referenced-by-count":76,"title":["Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients"],"prefix":"10.1016","volume":"53","author":[{"given":"Miao","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie Chiu Wing","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Ka Wai","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisaku","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P023614_bib1","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia."},{"key":"10.1194\/jlr.P023614_bib2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.22845","article-title":"Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population","volume":"49","author":"Gastaldelli","year":"2009","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science."},{"key":"10.1194\/jlr.P023614_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P023614_bib5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2796.2005.01528.x","article-title":"Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review","volume":"258","author":"Carlson","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1194\/jlr.P023614_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.pharmtox.48.113006.094746","article-title":"Nicotinic acid: pharmacological effects and mechanisms of action","volume":"48","author":"Gille","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1194\/jlr.P023614_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.0954-6820.1962.tb07203.x","article-title":"The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis","volume":"172","author":"Carlson","year":"1962","journal-title":"Acta Med. Scand."},{"key":"10.1194\/jlr.P023614_bib8","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2005.01.073","article-title":"Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia","volume":"95","author":"Vega","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.P023614_bib9","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1194\/jlr.M300403-JLR200","article-title":"Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells","volume":"45","author":"Ganji","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P023614_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.110.167478","article-title":"Nicotinic acid decreases apolipoprotein B100-containing lipoprotein levels by reducing hepatic very low density lipoprotein secretion through a possible diacylglycerol acyltransferase 2 inhibition in obese dogs","volume":"334","author":"Le Bloc'h","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1194\/jlr.P023614_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/hep.20783","article-title":"Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice","volume":"42","author":"Yu","year":"2005","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib12","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1210\/jc.2009-2622","article-title":"Effect of fenofibrate and niacin on intrahepatic triglyceride content, very low-density lipoprotein kinetics, and insulin action in obese subjects with nonalcoholic fatty liver disease","volume":"95","author":"Fabbrini","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.P023614_bib13","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/CS20080306","article-title":"The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans","volume":"116","author":"Kantartzis","year":"2009","journal-title":"Clin. Sci. (Lond.)."},{"key":"10.1194\/jlr.P023614_bib14","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mrm.22578","article-title":"Dual-echo Dixon imaging with flexible choice of echo times","volume":"65","author":"Eggers","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"10.1194\/jlr.P023614_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2156-8-17","article-title":"Mutation screen and association studies in the diacylglycerol O-acyltransferase homolog 2 gene (DGAT2), a positional candidate gene for early onset obesity on chromosome 11q13","volume":"8","author":"Friedel","year":"2007","journal-title":"BMC Genet."},{"key":"10.1194\/jlr.P023614_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2008.11.026","article-title":"Effects of extended-release niacin on lipid profile and adipocyte biology in patients with impaired glucose tolerance","volume":"205","author":"Linke","year":"2009","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P023614_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cmet.2007.05.005","article-title":"Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver","volume":"6","author":"Monetti","year":"2007","journal-title":"Cell Metab."},{"key":"10.1194\/jlr.P023614_bib20","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1194\/jlr.M007948","article-title":"Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease","volume":"51","author":"Wang","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P023614_bib21","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1194\/jlr.R800018-JLR200","article-title":"Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis","volume":"49","author":"Yen","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P023614_bib22","article-title":"Isolation, mapping, SNP detection and association with backfat traits of the porcine CTNNBL1 and DGAT2 genes","author":"Yin","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1194\/jlr.P023614_bib23","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib24","doi-asserted-by":"crossref","first-page":"E1012","DOI":"10.1152\/ajpendo.00650.2010","article-title":"Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue","volume":"300","author":"Oh","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1194\/jlr.P023614_bib25","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1210\/jc.2011-1104","article-title":"Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug","volume":"96","author":"Kang","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1194\/jlr.P023614_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology."},{"key":"10.1194\/jlr.P023614_bib27","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0b013e3282ff5e55","article-title":"Hepatic triglyceride synthesis and nonalcoholic fatty liver disease","volume":"19","author":"Choi","year":"2008","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.P023614_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jama.1994.03510330050033","article-title":"A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients","volume":"271","author":"McKenney","year":"1994","journal-title":"JAMA."},{"key":"10.1194\/jlr.P023614_bib29","doi-asserted-by":"crossref","first-page":"1645S","DOI":"10.1093\/ajcn\/65.5.1645S","article-title":"n-3 fatty acids and serum lipoproteins: human studies","volume":"65","author":"Harris","year":"1997","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.P023614_bib30","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2010.08.068","article-title":"Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg","volume":"213","author":"Wi","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P023614_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcn\/68.2.235","article-title":"Effect of fish-oil-enriched margarine on plasma lipids, low-density-lipoprotein particle composition, size, and susceptibility to oxidation","volume":"68","author":"S\u2298rensen","year":"1998","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.P023614_bib32","doi-asserted-by":"crossref","first-page":"228S","DOI":"10.1093\/ajcn\/71.1.228S","article-title":"Fish oil and cardiovascular disease: lipids and arterial function","volume":"71","author":"Nestel","year":"2000","journal-title":"Am. J. Clin. Nutr."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520405747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520405747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P023614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T21:46:26Z","timestamp":1637444786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520405747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0022227520405747"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p023614","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}